Methylprednisolone Terminated Phase 2 Trials for Neoplasms, Hepatic / Ischemic Reperfusion Injury / Insufficiency; Hepatic, Postoperative Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01726465Methylprednisolone N Acetylcysteine in Hepatic Resections